Top accelerator startups

14,448 startups · 29 programs

Granza Bio

Active · Building programmable therapeutics for the immune system

9signal of 100 · rising 4
  • team of 8Team size · YC's directory+4.9
  • went through YCProgram · this site+4

A sum of public facts, not a judgement and not investment advice.

Competitors

Adjacent

Also from W24

All of W24

About Granza Bio

Granza Bio is developing programmable therapeutics for the immune system. Our platform is built on the foundational discovery of immune “superkiller” attack particles, the natural ammunition used by cytotoxic immune cells to deliver potent, localized killing. By re-arming exhausted immune cells with newly programmed ammunition, Granza restores and enhances immune function. This approach enables a new class of treatments with the potential to transform diseases ranging from cancer to autoimmunity.

YC batch
W24 · Winter 2024
Status, per YC
Active
Category
Other
Team size
8
Location
San Francisco, CA, USA
Checked
10h ago

YC tags: Synthetic Biology, Biotech, Healthcare, Therapeutics, Oncology

Granza Bio in W24: 248 companies, 84% AI

Granza Bio: questions

Which YC batch was Granza Bio in?

Granza Bio was in Y Combinator's Winter 2024 batch (W24).

Is Granza Bio still active?

Y Combinator lists Granza Bio as active.

Where is Granza Bio based?

Granza Bio lists San Francisco, CA, USA as its location on YC's directory.